Clinical Trial Update: Vaccination with Autologous Dendritic Cells Loaded with Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer. [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating an autologous dendritic cell vaccine loaded with autologous tumor homogenate, given after curative resection for sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Autologous dendritic cell vaccine (tumor homogenate-loaded)

Snippet

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Conditions: Stage IV Colorectal Cancer, Curative Resection | Phase 2 | Status: RECRUITING